Stakeholder perspectives on ethical and trustworthy voice AI in health care
- PMID: 39055787
- PMCID: PMC11271113
- DOI: 10.1177/20552076241260407
Stakeholder perspectives on ethical and trustworthy voice AI in health care
Abstract
Objective: Voice as a health biomarker using artificial intelligence (AI) is gaining momentum in research. The noninvasiveness of voice data collection through accessible technology (such as smartphones, telehealth, and ambient recordings) or within clinical contexts means voice AI may help address health disparities and promote the inclusion of marginalized communities. However, the development of AI-ready voice datasets free from bias and discrimination is a complex task. The objective of this study is to better understand the perspectives of engaged and interested stakeholders regarding ethical and trustworthy voice AI, to inform both further ethical inquiry and technology innovation.
Methods: A questionnaire was administered to voice AI experts, clinicians, scholars, patients, trainees, and policy-makers who participated at the 2023 Voice AI Symposium organized by the Bridge2AI-Voice AI Consortium. The survey used a mix of Likert scale, ranking and open-ended questions. A total of 27 stakeholders participated in the study.
Results: The main results of the study are the identification of priorities in terms of ethical issues, an initial definition of ethically sourced data for voice AI, insights into the use of synthetic voice data, and proposals for acting on the trustworthiness of voice AI. The study shows a diversity of perspectives and adds nuance to the planning and development of ethical and trustworthy voice AI.
Conclusions: This study represents the first stakeholder survey related to voice as a biomarker of health published to date. This study sheds light on the critical importance of ethics and trustworthiness in the development of voice AI technologies for health applications.
Keywords: AI in medicine; biomarkers; data collection; ethical considerations; health data; health disparities; inclusivity; telehealth; trustworthiness; voice AI.
© The Author(s) 2024.
Conflict of interest statement
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
References
-
- Zhang L, Duvvuri R, Chandra KKL, et al. Automated voice biomarkers for depression symptoms using an online cross-sectional data collection initiative. Depress Anxiety 2020; 37: 657–669. - PubMed
-
- Tracy JM, Özkanca Y, Atkins DC, et al. Investigating voice as a biomarker: deep phenotyping methods for early detection of Parkinson’s disease. J Biomed Inform 2020; 104: 103362. - PubMed
-
- Sara JD S, Orbelo D, Maor E, et al. Guess what we can hear – novel voice biomarkers for the remote detection of disease. Mayo Clin Proc 2023; 98: 1353–1375. https://www.sciencedirect.com/science/article/pii/S0025619623001301. [cited 2023 Aug 3]. - PMC - PubMed
LinkOut - more resources
Full Text Sources
